Finance and markets: business, quotes, gold, energy and releases.
Found 47797 articles
Sara Bonstein, who has served as the chief financial officer of Insmed Incorporated for nearly seven years, will vacate her position on October 30. Her departure arrives as the Bridgewater-based biopharmaceutical firm prepares for its third-quarter earnings report, with the company confirming it has already initiated a search for her successor.
Redmond-based Halfpricesoft.com has introduced new features for its ezPaycheck software, aiming to help small and mid-sized businesses bypass recurring subscription fees. By moving payroll and tax filing in-house, companies can now manage complex W-2 and 941 filings while avoiding the per-employee charges typical of cloud-based platforms.
For the sixth year running, digital personal finance firm Achieve has secured a spot on Arizona’s Most Admired Companies list. The annual selection, curated by Az Business magazine and BestCompaniesAZ, highlights the organization’s persistent focus on employee development, community engagement, and its broader mission of stabilizing consumer debt.
Quantinuum and The University of Western Australia have signed a memorandum of understanding to integrate quantum computing, artificial intelligence, and high-performance computing into the nation's industrial landscape. The collaboration provides local researchers and entrepreneurs with direct access to Helios, the company's high-fidelity commercial quantum computing platform.
Peggy Johnson, head of humanoid robotics firm Agility Robotics, has been tapped to join Project Meridian, a Department of War-commissioned initiative led by The MITRE Corporation. The group aims to shape national security strategy and defense investment priorities through a long-term assessment of emerging technology over the next two decades.
A new study published in Nature Medicine demonstrates that a non-invasive urine test can move beyond simple cancer detection to predict how specific tumors will respond to immunotherapy. By analyzing cell-free RNA, researchers identified molecular signatures that distinguish tumor aggressiveness and residual disease without requiring surgical tissue biopsies.
Recross Cardio has reached the 25-subject threshold in its PROTEA-PFO clinical program, a multicenter study evaluating a novel membrane-based sealing system. The trial, currently active across the United States and Serbia, assesses the safety and performance of the device in patients who have suffered ischemic strokes due to paradoxical embolism.
ECARX Holdings has completed its acquisition of the Flyme software portfolio from DreamSmart Group for 1.8 billion RMB, securing full control over the Flyme Auto cockpit system and Flyme OS. This all-cash deal integrates critical R&D assets and intellectual property directly into the London-based automotive intelligence company's technology stack.
Houston-based Superior Hydrovac has expanded its regional footprint through the acquisition of Delta Daylighting, a local provider specializing in non-destructive excavation. The move integrates Delta’s workforce and existing client contracts into Peak Utility Services Group’s broader infrastructure platform to bolster capacity across the competitive Texas utility market.
Raleigh-based self-storage operator 10 Federal has appointed a new executive leadership team, naming Geoff Hayth as President and Chief Customer Experience Officer, Beau Agnello as Chief Operating Officer, and promoting Brian Oakley to Chief Technology Officer to spearhead a major phase of corporate growth.
With an oversubscribed pre-seed round closed, Baltimore-based SereNeuro Therapeutics is accelerating its lead non-opioid program, SN101. The biotech firm aims to move its iPSC-derived therapy toward IND-enabling studies, leveraging unique cellular biology to treat chronic joint pain without the addictive risks associated with traditional opioid-based interventions.
Former CyberArk CEO Matt Cohen is joining Keyfactor’s board of directors and serving as a strategic advisor to CEO Jordan Rackie, a move aimed at guiding the company through its next phase of rapid expansion following a recent $1 billion-plus growth investment led by Summit Partners.
Tokyo-based Ajinomoto Bio-Pharma Services has launched a global brand refresh, updating its visual identity and digital presence to emphasize its niche capabilities. The move aims to better position the contract development and manufacturing organization as a specialized partner for complex drug development amid tightening industry requirements.
Investors are looking toward October 29, 2026, when SiriusXM will disclose its operating and financial results for the third quarter. The audio entertainment giant scheduled an 8:00 a.m. ET conference call that morning to dissect the performance of its streaming and subscription platforms before the market opens.
Sugar Land-based Applied Optoelectronics has finalized its latest at-the-market equity program, securing approximately $588 million in net proceeds. The company issued 5,694,845 shares of common stock at an average price of $105.36 per share, marking its third successful capital raise through this mechanism within the current year.
Tokyo-based Ajinomoto Bio-Pharma Services has launched a refreshed global brand identity, signaling a strategic pivot toward deep technical specialization. The move updates the company's visual identity and digital presence to better reflect its core capability in navigating complex manufacturing challenges for the global biopharmaceutical sector.
AerCap Holdings N.V. navigated a high-volume third quarter in 2026, facilitating 204 distinct asset transactions across its global portfolio. The Dublin-based aviation lessor balanced fleet turnover with aggressive capital management, closing 85 lease agreements and 85 sales while finalizing nearly $900 million in new financing deals.
While brands flood TikTok and YouTube with creative assets, a new report from Zappi reveals a sharp disconnect between grabbing attention and driving sales. Analysis of 3,300 social ads shows that viral hooks often fail to persuade consumers or foster the long-term brand recognition necessary for market growth.
A 110,000-square-foot manufacturing plant in Franklin County has officially begun tea production, marking a strategic shift toward bicoastal operations for the botanical wellness brand. The $47 million site serves as the company’s first expansion outside its original California headquarters, aiming to streamline distribution and meet rising national demand.
On Saturday, October 10, the educational series Advancements with Ted Danson returns to Bloomberg Television at 8:00 p.m. ET. The upcoming episode examines how emerging technologies and integrated systems are reshaping behavioral healthcare, battery sustainability, industrial automation, and remote medical monitoring to meet modern global demands.
Quantinuum and The University of Western Australia have signed a memorandum of understanding to integrate quantum computing into the nation’s research and industrial sectors. The collaboration grants students and researchers cloud-based access to the Helios quantum computer to develop hybrid AI-HPC workflows for critical industries like energy and healthcare.
Seventy-six percent of Americans report feeling burned out by constant notifications and packed schedules, prompting Southwest Airlines to launch a new campaign that rewards travelers for disconnecting. The initiative, titled "Enter Airplane Mode," incentivizes customers to trade their digital stressors for travel points and potential getaways.
The global organic fertilizer market is set for rapid expansion, with valuations expected to climb from $9.80 billion in 2026 to $17.08 billion by 2031. Driven by an 11.8% compound annual growth rate, the sector is benefiting from a structural shift toward soil health, residue-free produce, and sustainable agriculture.
David Borde has stepped into the roles of president and CEO at Entergy Texas, effective October 5. He succeeds Eliecer Viamontes, who leaves the regional utility provider to pursue other professional opportunities. The leadership transition marks a shift for the company as it navigates evolving regulatory and customer demands.
Hyperscale Data will host a virtual investor day on November 12, 2026, to outline the progress of its Michigan AI data center campus and evaluate strategic alternatives for its diverse business portfolio. The session aims to clarify the company's path toward enhancing stockholder value amidst ongoing infrastructure development.
The global A2L refrigerant market is set for significant expansion, with projections indicating a rise from $4.02 billion in 2026 to $5.92 billion by 2031. Driven by a global shift away from high-GWP HFCs, the sector is growing at a compound annual rate of 8.1% as industries prioritize energy-efficient cooling technology.
As global leaders prepare for the COP31 climate conference in Türkiye, the Calgary-based Friends of Science Society is positioning itself as a contrarian voice. On November 16, 2026, the organization will host meteorologist Anthony Watts to present an argument that current climate anxieties are based on flawed data rather than reality.
Investors who purchased Hyliion Holdings Corp. stock between May 12 and June 23, 2026, face an October 27 deadline to seek lead plaintiff status in a class action lawsuit. The litigation targets alleged misrepresentations regarding a partnership deal that purportedly facilitated insider trading and triggered significant market losses.
Ahead of the TOKEN2049 conference in Singapore, crypto exchange MEXC and Payward, the parent company of Kraken, have initiated talks to explore a cross-platform partnership. Executives plan to formalize these discussions on October 7, targeting a new framework for global liquidity and infrastructure as market demands shift.
The U.S. Food and Drug Administration has cleared HanchorBio’s investigational new drug application for HCB303, a next-generation trispecific immunotherapy. This regulatory milestone allows the company to launch a Phase 1, multi-regional, first-in-human dose-escalation trial targeting patients with advanced, treatment-resistant solid tumors.